Hindustan Latex Limited (HLL) has drawn up an ambitious turnover target of Rs. 1000 crore by 2010 and to achieve this it has chalked out a comprehensive plan of expanding its portfolio of health care and contraceptive products.

The company has signed an Memorandum of Understanding with M/s AIMU Medical Science and Technology Ltd., Anshan, China for introducing a new generation of intra uterine devices (IUD).

“The IUDs are Memory MCU IUDs. The uniqueness of these IUDs is that they regain their original shape, even if distorted, at body temperature. The Memory IUD has an effective life of over 8 years,” said the company sources.

HLL has commenced the marketing of its spiral condoms by the brand name MOODS. The product was launched at Hyderabad recently.

Further, the company has launched women’s health care pharma division to cater to the reproductive healthcare needs of women. The division will initially focus on the gynaecology segment, the products of which will be promoted by the doctors. All products for this division will be manufactured at HLL’s Kanagala Plant.

The division will cover all sectors of women health issues like autoimmune diseases, hormone- gynaecological infections, sexually transmitted diseases, hormone related disorders, osteoporosis, cancer and urinary bladder disorders.

Another major project on the anvil is the production of anti retro viral (ARV) drug. The commercial production will be undertaken by Kanagala plant for which the formulation development is under progress. Trial license from the state drugs control authority has been obtained.